Across TCGA pan-cancer cohorts, RNU6-407P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNU6-407P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RNU6-407P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-407P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

HNSC, KIRC, and COAD are the cancer types where RNU6-407P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-407P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.402	.001	8	view →
KIRC	All	All	+0.208	.008	5	view →
COAD	All	All	+0.431	.001	4	view →
LIHC	All	All	+0.135	.008	4	view →
CHOL	All	All	+0.794	.003	2	view →
BRCA	All	III,IV	−0.412	.041	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

Exploration

Same gene, other analysis: RNU6-407P RNA expression & survival · all RNU6-407P data types